Global SaMD Registration & Market Expansion

Expanding into international markets requires more than innovation, it demands a structured approach to global Software as a Medical Device (SaMD) registrations and compliance. Freyr helps SaMD and Digital Health innovators navigate complex regulatory environments, enabling compliant entry into 120+ global markets through strategic planning, execution, and lifecycle support.

With deep expertise in SaMD compliance and region-specific regulatory frameworks, we streamline approval pathways and reduce uncertainty across global jurisdictions.

  • 160

    +

    Global SaMD Regulatory Registrations
  • 120

    +

    Regulatory Markets Covered
  • 1500

    +

    Regulatory Projects Across the Product Lifecycle

Speak to our Experts

Global SaMD Registration & Regulatory Strategy

Software as a Medical Device (SaMD) is expanding rapidly worldwide as AI-driven diagnostics, remote monitoring, and connected care models scale into routine clinical use. Regulators are responding by raising expectations for software lifecycle controls, evidence generation, and transparency, making Global SaMD registration increasingly influenced by real-world performance, cybersecurity readiness, and the ability to demonstrate consistent benefit across diverse healthcare settings. As a result, successful market entry is no longer only about approvals, but about sustaining trust and compliance as products evolve.

For manufacturers and MedTech businesses, this shift creates opportunity and complexity. Teams must interpret evolving SaMD regulations and align a regulatory strategy for SaMD across markets with different definitions, classification approaches, and review pathways, whether preparing for FDA SaMD submissions, Health Canada registration, SaMD PMDS Japan regulation, or SaMD TGA Australia requirements. Meanwhile, inconsistent planning for clinical evaluation, QMS maturity, and cybersecurity compliance can also increase rework.

Freyr helps companies turn this into a scalable advantage by building a cohesive SaMD global regulatory strategy that connects classification, standards mapping, QMS implementation (ISO 13485), clinical evidence planning, and submission readiness into one coordinated approach. With market-specific intelligence and execution support, we enable efficient SaMD registration and sustained compliance across global geographies.

Freyr Enables End-to-End Global Market Expansion for SaMD

Whether entering established markets like the U.S. and EU or expanding into APAC, LATAM, or the Middle East, Freyr provides end-to-end support for SaMD registration and ongoing compliance.

Our services include:

  • Global risk classification and regulatory pathway alignment
  • SaMD clinical evaluation and evidence planning
  • SaMD cybersecurity compliance aligned with regional guidance
  • UDI, labeling, and post-market obligations
  • AI/ML regulatory considerations under evolving global frameworks

Freyr ensures your global expansion strategy is compliant, efficient, and future-ready.

SaMD QMS Services for Global Registration

A scalable Quality Management System is critical to sustaining global approvals. Freyr supports SaMD QMS implementation (ISO 13485) and software lifecycle compliance to help manufacturers maintain audit readiness across markets.

Our SaMD QMS services include:

  • QMS design and implementation aligned with ISO 13485 and IEC 62304
  • Localization of processes for multi-country operations
  • Integration of risk management, cybersecurity, and change control
  • Support for regulatory inspections and audits worldwide
 

Why Partner with Freyr?

  • Proven expertise in global SaMD registration across 120+ markets and high-risk products
  • Deep experience in SaMD compliance, QMS, and clinical evaluation
  • Strong regulatory coverage across FDA, EU MDR, Health Canada, PMDA, and TGA
  • Integrated cybersecurity and AI/ML regulatory support
  • Trusted global partner for scalable, audit-ready market expansion

Frequently Asked Questions

01. What does global SaMD registration involve?

Global SaMD registration includes regulatory strategy development, risk classification, clinical evaluation, QMS alignment, cybersecurity compliance, and market-specific submissions. Each region has distinct requirements, making a coordinated global approach essential to avoid delays, duplication, and compliance risks while expanding into multiple markets.

02. How does SaMD compliance differ across global markets?

While principles are aligned, SaMD compliance varies by region. FDA SaMD pathways focus on risk-based submissions, the EU MDR emphasizes clinical evidence and lifecycle oversight, and markets like Japan, Australia, and Canada impose additional local requirements, making region-specific regulatory strategies critical.

03. What role does QMS play in global SaMD registration?

A compliant QMS under ISO 13485 and IEC 62304 is foundational for global SaMD registration. It ensures consistent software lifecycle controls, risk management, and post-market compliance, supporting approvals across multiple jurisdictions and enabling efficient scaling.

04. How does cybersecurity impact SaMD registration?

SaMD cybersecurity compliance is a growing regulatory focus worldwide. Authorities increasingly expect documented risk assessments, secure development practices, and post-market monitoring to address vulnerabilities, particularly for connected and AI-enabled medical software.

05. Why is a global regulatory strategy important for SaMD expansion?

A unified SaMD global regulatory strategy aligns development, evidence generation, and submissions across markets, reducing rework, accelerating approvals, and ensuring long-term compliance as regulatory requirements evolve.

06. Why is Freyr considered a preferred partner for global SaMD registration and market expansion?

Freyr is widely recognized for its ability to support end-to-end global SaMD registration by combining regulatory strategy, QMS implementation, clinical evaluation planning, and market-specific execution under one integrated model. With experience across FDA, EU MDR, Health Canada, PMDA, and TGA pathways, Freyr enables consistent, scalable, and compliant market access for SaMD innovators worldwide.